Lindsay Cormier, PhD, MPH

In this opinion article, the authors discuss their concerns about the recent HICPAC/CDC proposals on infectious diseases.

Post-COVID-19 immune dysfunction is supported by epidemiological, clinical, and laboratory evidence. Attributing, with little to no evidence, that masking and lack of exposure is the primary driver of increases in bacterial and viral infections discourages critical interventions needed to stop the spread of disease.

If you are on one of these medications one should perform strict social distancing and protect yourself from contracting COVID-19.

ACE inhibitors up regulate (increase) the ACE2 receptor. This is the receptor the COVID-19 virus uses to attack the lungs.